https://european-biotechnology.net/wp-content/uploads/2025/07/EC-Life-Sciences-Strategy-e1751894302405.jpg360639Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-07-07 13:41:172025-07-07 13:41:17European Commission to fund Life Sciences Strategy using Cohesion Fund resources
https://european-biotechnology.net/wp-content/uploads/2025/07/Vetter-e1751364099507.jpg304540Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-07-01 13:39:202025-07-01 13:39:20Vetter invests US$285m in Chicago production facility
https://european-biotechnology.net/wp-content/uploads/2025/06/Plectonic-e1750752296578-1030x580-1.webp5801030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-06-24 08:07:252025-06-27 08:52:40Sonrai and Plectonic Biotech partner to advance cancer immunotherapies
